Last reviewed · How we verify
Actiq 400 mcg
At a glance
| Generic name | Actiq 400 mcg |
|---|---|
| Sponsor | Mallinckrodt |
| Modality | Small molecule |
| Phase | Phase 1 |
Approved indications
Common side effects
Key clinical trials
- Impact of ERAS Protocol on Length of Hospital Stay After Laparoscopic Surgeries (PHASE4)
- Psychosocial Factors and Postoperative Pain in Aesthetic Breast Surgery
- Interscalene Block vs Serratus Posterior Superior Intercostal Plane Block (NA)
- Modified Thoracoabdominal Nerve Plane Block In Laparoscopic Sleeve Gastrectomy (NA)
- Para-sartorial Compartment Block in Knee Surgery (NA)
- SPSIPB vs SAPB for Thoracoscopic Surgery (NA)
- Non-opioid Anesthesia Based on Thoracic Paravertebral Block During Laparoscopic Sleeve Gastrectomy (NA)
- Serratus Posterior Superior Intercostal Plane Block for Arthroscopic Shoulder Surgery (NA)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Actiq 400 mcg CI brief — competitive landscape report
- Actiq 400 mcg updates RSS · CI watch RSS
- Mallinckrodt portfolio CI